Overexpression of human diacylglycerol acyltransferase 1, acyl-coa:cholesterol acyltransferase 1, or acyl-CoA:cholesterol acyltransferase 2 stimulates secretion of apolipoprotein B-containing lipoproteins in McA-RH7777 cells.
The relative importance of each core lipid in the assembly and secretion of very low density lipoproteins (VLDL) has been of interest over the past decade. The isolation of genes encoding diacylglycerol acyltransferase (DGAT) and acyl-CoA:cholesterol acyltransferases (ACAT1 and ACAT2) provided the opportunity to investigate the effects of isolated increases in triglycerides (TG) or cholesteryl esters (CE) on apolipoprotein B (apoB) lipoprotein biogenesis. Overexpression of human DGAT1 in rat hepatoma McA-RH7777 cells resulted in increased synthesis, cellular accumulation, and secretion of TG. These effects were associated with decreased intracellular degradation and increased secretion of newly synthesized apoB as VLDL. Similarly, overexpression of human ACAT1 or ACAT2 in McA-RH7777 cells resulted in increased synthesis, cellular accumulation, and secretion of CE. This led to decreased intracellular degradation and increased secretion of VLDL apoB. Overexpression of ACAT2 had a significantly greater impact upon assembly and secretion of VLDL from liver cells than did overexpression of ACAT1. The addition of oleic acid (OA) to media resulted in a further increase in VLDL secretion from cells expressing DGAT1, ACAT1, or ACAT2. VLDL secreted from DGAT1-expressing cells incubated in OA had a higher TG:CE ratio than VLDL secreted from ACAT1- and ACAT2-expressing cells treated with OA. These studies indicate that increasing DGAT1, ACAT1, or ACAT2 expression in McA-RH7777 cells stimulates the assembly and secretion of VLDL from liver cells and that the core composition of the secreted VLDL reflects the enzymatic activity that is elevated.
Liang
John J
JJ
Department of Medicine, Columbia University Medical Center, New York, New York 10032, USA.
Oelkers
Peter
P
Guo
Cuiying
C
Chu
Pi-Chun
PC
Dixon
Joseph L
JL
Ginsberg
Henry N
HN
Sturley
Stephen L
SL
D000217:Acyltransferases / Q000096:biosynthesis* / Q000378:metabolism; D000818:Animals; D001055:Apolipoproteins B / Q000096:biosynthesis*; D006528:Carcinoma, Hepatocellular / Q000378:metabolism; D002499:Centrifugation, Density Gradient; D002788:Cholesterol Esters / Q000378:metabolism; D002855:Chromatography, Thin Layer; D016895:Culture Media, Serum-Free / Q000494:pharmacology; D051048:Diacylglycerol O-Acyltransferase; D006801:Humans; D047468:Immunoprecipitation; D050356:Lipid Metabolism; D008055:Lipids / Q000737:chemistry; D008074:Lipoproteins / Q000737:chemistry; D019301:Oleic Acid / Q000737:chemistry; D051381:Rats; D002785:Sterol O-Acyltransferase / Q000096:biosynthesis*; D013395:Sucrose / Q000494:pharmacology; D013997:Time Factors; D014162:Transfection; D014280:Triglycerides / Q000737:chemistry; D000097587:Sterol O-Acyltransferase 2
D000217:Acyltransferases; D001055:Apolipoproteins B; D002788:Cholesterol Esters; D016895:Culture Media, Serum-Free; D051048:Diacylglycerol O-Acyltransferase; D008055:Lipids; D008074:Lipoproteins; D019301:Oleic Acid; D002785:Sterol O-Acyltransferase; D013395:Sucrose; D014280:Triglycerides; D000097587:Sterol O-Acyltransferase 2; C494881:DGAT1 protein, human; C494883:Dgat1 protein, rat